Management of Anticoagulation for Transesophageal Echocardiogram (TEE) Procedures
Risk Assessment and Anticoagulation Management
- The American College of Cardiology/American Heart Association/European Society of Cardiology recommends that TEE is considered a low-bleeding risk procedure that can be safely performed while maintaining therapeutic anticoagulation in patients with atrial fibrillation or other high thrombotic risk conditions 1, 2
- For patients with atrial fibrillation or other high-risk conditions, maintaining anticoagulation is critical to prevent thromboembolic events, and guidelines do not recommend discontinuation of anticoagulation for diagnostic TEE procedures 2, 3
- In patients with atrial fibrillation or atrial flutter, TEE is often used specifically to identify left atrial appendage thrombus, and interrupting anticoagulation could potentially increase thromboembolic risk 3, 4
Special Considerations for Anticoagulation
- For patients undergoing TEE-guided cardioversion, intravenous heparin should be administered before the procedure and continued afterward if the patient is not already on adequate anticoagulation, according to the European Society of Cardiology 1, 6
- In cases of hemodynamic instability requiring immediate cardioversion after TEE, intravenous unfractionated heparin or subcutaneous low-molecular-weight heparin should be initiated before the procedure, as recommended by the European Heart Journal 3, 4
Potential Exceptions and Pitfalls
- In the extremely rare case of patients with known esophageal varices or other high-risk esophageal pathology where the risk of bleeding during TEE is substantially elevated, individual risk assessment may be warranted, according to the European Society of Gastroenterology 7
- Unnecessarily holding anticoagulation before TEE, which could increase thromboembolic risk, especially in high-risk patients, is a common pitfall to avoid, as stated by the American College of Chest Physicians 2, 5